Recent Insights & Interviews
Innovators in the field who share their insights with 7investing
Featured
Growth Style Investing with 7investing CEO Simon Erickson
This growth-style investing approach is exactly what is preferred by 7investing founder and CEO Simon Erickson. In a conversation with Robert Leonard of Millennial Investing, Simon describes his investing process and what it means to be a growth-style investor. He explains the drivers of why stock prices go up (or down) over time, the role of leadership in valuation, and a few landmines investors should always avoid.
Recent Insights/Interviews
7investing and CryptoEQ in April: The $2 Trillion Milestone, Coinbase Goes Public, and Crypto Innovators
7investing and CryptoEQ are now hosting monthly calls for subscribers to get a better understanding of the collision of cryptocurrencies and equities. This month, the teams discuss crypto's overall market cap, Coinbase's upcoming direct listing, and several companies who are ahead of the curve in adopting cryptocurrencies.
Log In to Read more
Is Quantum Computing About to Disrupt Everything?
Quantum computing is about to make a quantum leap in the commercial world. Is it worth the risk for investors?
Log In to Read more
Is Value the New Growth?
Value stocks have drastically outperformed tech-centric growth plays in recent months. But don't give up on growth just yet.
Log In to Read more
The Changing Face of Retail with Dan Kline
7investing's very own Dan Kline chats with Simon Erickson about changes taking place in the retail industry.
Listen to podcast
Can Amazon, Apple, or Google Disrupt the Healthcare Market?
Big tech has the money and major incentive to disrupt healthcare and they can start with their own employees as a test lab of sorts.
Read full article
What Is the Future of Value-based Healthcare?
While nobody knows what the future of healthcare will be, it's very clear that some major changes are going on. Simon Erickson explores how value will play a role.
Read full article
What’s next for mRNA?
Most Americans had never heard of mRNA before the COVID-19 vaccines, but it has been worked on for over 30 years.
Read full article
Running with Scissors: Will CRISPR be Humbled in the Clinic?
The future is bright for CRISPR systems, but maybe less so for CRISPR gene editing. Either way, there's a long (and potentially painful) road ahead.
Log In to Read more
Meet the First Public Quantum Computing Company
There's now a publicly-traded quantum computing company. What does that mean?
Read full article
